AL
$11.10
-0.26
(-2.29%)
As of Sep 5, 2026, 11:36 AM EDT
Price history
Alumis Inc (ALMS) is trading down at $11.10 (-2.29%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: June 28, 2024 · $16.00 offering · NASDAQ · View IPO details →
Recent News (7)
-
Alumis to Participate in Upcoming September Investor Conferences SOUTH SAN FRANCISCO, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharmaceutical company developing next-generation targeted therapies for patients with imm…
-
Guggenheim downgrades Alumis stock rating after trial miss
Guggenheim downgrades Alumis stock rating after trial miss
-
Tesla, Apple, Nvidia, Medtronic, Alumis, Robinhood, Fervo, and More Stocks That Explain Today’s Market
Tesla, Apple, Nvidia, Medtronic, Alumis, Robinhood, Fervo, and More Stocks That Explain Today’s Market
-
Why is Alumis stock collapsing today?
Why is Alumis stock collapsing today?
-
Alumis stock tumbles 55% after lupus drug trial misses goals
Alumis stock tumbles 55% after lupus drug trial misses goals
-
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE) Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
-
H.C. Wainwright reiterates Alumis stock rating at neutral, $25 target
H.C. Wainwright reiterates Alumis stock rating at neutral, $25 target
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International